215 related articles for article (PubMed ID: 26086919)
1. Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule.
Vyklicky V; Krausova B; Cerny J; Balik A; Zapotocky M; Novotny M; Lichnerova K; Smejkalova T; Kaniakova M; Korinek M; Petrovic M; Kacer P; Horak M; Chodounska H; Vyklicky L
Sci Rep; 2015 Jun; 5():10935. PubMed ID: 26086919
[TBL] [Abstract][Full Text] [Related]
2. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.
Hubalkova P; Ladislav M; Vyklicky V; Smejkalova T; Hrcka Krausova B; Kysilov B; Krusek J; Naimová Z; Korinek M; Chodounska H; Kudova E; Cerny J; Vyklicky L
J Neurosci; 2021 Mar; 41(10):2119-2134. PubMed ID: 33526476
[TBL] [Abstract][Full Text] [Related]
4. A structurally derived model of subunit-dependent NMDA receptor function.
Gibb AJ; Ogden KK; McDaniel MJ; Vance KM; Kell SA; Butch C; Burger P; Liotta DC; Traynelis SF
J Physiol; 2018 Sep; 596(17):4057-4089. PubMed ID: 29917241
[TBL] [Abstract][Full Text] [Related]
5. Site within N-Methyl-D-aspartate receptor pore modulates channel gating.
Chen N; Li B; Murphy TH; Raymond LA
Mol Pharmacol; 2004 Jan; 65(1):157-64. PubMed ID: 14722247
[TBL] [Abstract][Full Text] [Related]
6. Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.
Kashiwagi K; Masuko T; Nguyen CD; Kuno T; Tanaka I; Igarashi K; Williams K
Mol Pharmacol; 2002 Mar; 61(3):533-45. PubMed ID: 11854433
[TBL] [Abstract][Full Text] [Related]
7. Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits.
Kashiwagi K; Pahk AJ; Masuko T; Igarashi K; Williams K
Mol Pharmacol; 1997 Oct; 52(4):701-13. PubMed ID: 9380034
[TBL] [Abstract][Full Text] [Related]
8. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of differential control of NMDA receptor activity by NR2 subunits.
Gielen M; Siegler Retchless B; Mony L; Johnson JW; Paoletti P
Nature; 2009 Jun; 459(7247):703-7. PubMed ID: 19404260
[TBL] [Abstract][Full Text] [Related]
10. Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.
Kysilov B; Kuchtiak V; Hrcka Krausova B; Balik A; Korinek M; Fili K; Dobrovolski M; Abramova V; Chodounska H; Kudova E; Bozikova P; Cerny J; Smejkalova T; Vyklicky L
Cell Mol Life Sci; 2024 Jan; 81(1):36. PubMed ID: 38214768
[TBL] [Abstract][Full Text] [Related]
11. A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices.
Moldavski A; Behr J; Bading H; Bengtson CP
J Physiol; 2020 Feb; 598(4):633-650. PubMed ID: 31876958
[TBL] [Abstract][Full Text] [Related]
12. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
[TBL] [Abstract][Full Text] [Related]
13. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.
Kysilov B; Hrcka Krausova B; Vyklicky V; Smejkalova T; Korinek M; Horak M; Chodounska H; Kudova E; Cerny J; Vyklicky L
Br J Pharmacol; 2022 Aug; 179(15):3970-3990. PubMed ID: 35318645
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
Mony L; Kew JN; Gunthorpe MJ; Paoletti P
Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
[TBL] [Abstract][Full Text] [Related]
15. A neuroactive steroid with a therapeutically interesting constellation of actions at GABA
Ziolkowski L; Mordukhovich I; Chen DM; Chisari M; Shu HJ; Lambert PM; Qian M; Zorumski CF; Covey DF; Mennerick S
Neuropharmacology; 2021 Feb; 183():108358. PubMed ID: 33115614
[TBL] [Abstract][Full Text] [Related]
16. DRPEER: a motif in the extracellular vestibule conferring high Ca2+ flux rates in NMDA receptor channels.
Watanabe J; Beck C; Kuner T; Premkumar LS; Wollmuth LP
J Neurosci; 2002 Dec; 22(23):10209-16. PubMed ID: 12451122
[TBL] [Abstract][Full Text] [Related]
17. NR3A modulates the outer vestibule of the "NMDA" receptor channel.
Wada A; Takahashi H; Lipton SA; Chen HS
J Neurosci; 2006 Dec; 26(51):13156-66. PubMed ID: 17182766
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of NMDA channels requires ligand binding to both GluN1 and GluN2 subunits to constrict the pore beside the activation gate.
Chen YS; Tu YC; Lai YC; Liu E; Yang YC; Kuo CC
J Neurochem; 2020 Jun; 153(5):549-566. PubMed ID: 31821563
[TBL] [Abstract][Full Text] [Related]
19. Noncompetitive, voltage-dependent NMDA receptor antagonism by hydrophobic anions.
Linsenbardt AJ; Chisari M; Yu A; Shu HJ; Zorumski CF; Mennerick S
Mol Pharmacol; 2013 Feb; 83(2):354-66. PubMed ID: 23144238
[TBL] [Abstract][Full Text] [Related]
20. All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water.
Mesbahi-Vasey S; Veras L; Yonkunas M; Johnson JW; Kurnikova MG
PLoS One; 2017; 12(6):e0177686. PubMed ID: 28582391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
